You can edit almost every page by Creating an account and confirming your email.

1Life

From EverybodyWiki Bios & Wiki

1Life Insurance is a South African life insurance company based in Dainfern, Johannesburg.[1]

History

1Life Insurance was founded in 2006 and began its operations as a direct life insurer in South Africa.[1] In 2012, the company introduced a USSD policy management service for its policyholders and adopted saliva-based HIV testing as an alternative to blood tests.[2]

By 2021, the company introduced its own brokerage service.[2]

In June 2021, 1Life collaborated with LifeQ and Samsung South Africa to develop a COVID-19 screening app.[3] The app uses physiological data combined with user input to provide early alerts for potential infections even before symptoms appear.[3]

In April 2023, 1Life Insurance introduced a product, the 1Life Wills and Estate Plan, designed to address estate planning issues, including estate liquidity shortfalls.[4]

In November 2023, it was announced that Clientèle will acquire 1Life Insurance from Telesure Investment Holdings for R1.91 billion.[5][6] The acquisition will be completed by June 2024.[7]

References

  1. ↑ 1.0 1.1 "Clientèle to acquire 1Life in a R1.91bn share swop transaction".
  2. ↑ 2.0 2.1 "About 1Life | Life Insurance Company in South Africa". 1Life Insurance. August 22, 2012.
  3. ↑ 3.0 3.1 "1Life, LifeQ and Samsung SA collaborate to launch Covid-19 screening app".
  4. ↑ "1Life Insurance's new product helps advisers protect and transfer clients' generational wealth".
  5. ↑ https://www.moneyweb.co.za/news/companies-and-deals/clientele-to-merge-with-1life-insurance/
  6. ↑ Theunissen, Garth. "Clientèle bulks up with R1.9bn acquisition of 1Life". Business.
  7. ↑ "Clientèle acquires 1Life in R1.9bn deal".


This article "1Life" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:1Life. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.